NOTCH1 and urinary bladder carcinoma: They evaluated the activity of NOTCH1 and MAPK pathways in advanced stages (III and IV) of bladder cancer tissue samples from patients treated with radical cystectomy and assessed their relationship with clinical outcomes, such as cancer-specific survival and overall survival.